WallStreetZenWallStreetZen

NASDAQ: VNDA
Vanda Pharmaceuticals Inc Stock Ownership - Who owns Vanda Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vanda Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Timothy WilliamsSVP General Counsel2026-03-0242,434$8.27
$350.76kSell
Kevin Patrick MoranSVP CFO Treasurer2026-03-0242,442$8.27
$350.83kSell
Gunther BirznieksSVP Business Development2026-03-0242,431$8.27
$350.73kSell
Mihael Hristos PolymeropoulosPresident and CEO2026-03-02156,235$8.17
$1.28MSell
Joakim WijkstromSVP Chief Marketing Officer2026-03-0230,800$8.27
$254.59kSell
Tage HonoreDirector2026-02-2330,000$8.03
$240.90kSell
Mihael Hristos PolymeropoulosPresident and CEO2025-08-0710,000$4.15
$41.50kBuy

1 of 1

VNDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VNDA insiders and whales buy or sell their stock.

VNDA Shareholders

What type of owners hold Vanda Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn14.42%8,669,076$44.91MInsider
Blackrock Inc12.10%7,275,988$37.69MInstitution
Renaissance Technologies LLC6.25%3,759,559$19.47MInstitution
State Street Corp5.01%3,015,562$15.62MInstitution
Aigh Capital Management LLC4.57%2,750,000$14.25MInstitution
Kevin C. Tang4.52%2,715,852$14.07MInsider
Mihael Hristos Polymeropoulos4.50%2,704,496$14.01MInsider
Rho Ventures IV LP4.19%2,518,177$13.04MInsider
Vanguard Capital Management LLC4.13%2,481,491$12.85MInstitution
Nicole Vitullo3.32%1,995,976$10.34MInsider

1 of 3

VNDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VNDA52.43%47.57%Net Selling
IRD12.84%87.16%Net SellingNet Selling
LYEL8.02%91.98%Net BuyingNet Selling
AGEN6.56%93.44%Net BuyingNet Buying
NMRA30.07%69.93%Net Buying
View Top Biotech Stocks

Vanda Pharmaceuticals Stock Ownership FAQ

Who owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals (NASDAQ: VNDA) is owned by 76.85% institutional shareholders, 69.74% Vanda Pharmaceuticals insiders, and 0.00% retail investors. James E. Flynn is the largest individual Vanda Pharmaceuticals shareholder, owning 8.67M shares representing 14.42% of the company. James E. Flynn's Vanda Pharmaceuticals shares are currently valued at $44.21M.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.